TOKYO -- As nerves fray over tariff threats from U.S. President Donald Trump, large Japanese pharmaceutical companies have largely held their value even as other manufacturers like autos and semiconductors have endured a market sell-off.
Pharmaceuticals
Japan drug companies offer rare haven amid Trump market jitters
Most big-cap stocks make year-to-date gains even as 25% tariff looms
Japanese pharmaceutical stocks have been relatively strong performers despite the looming threat of tariffs. (Nikkei montage/Source photo by AP)
Read Next
.JPG?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Pharmaceuticals
